✦ LIBER ✦

Entecavir for lamivudine-naïve patients with chronic hepatitis B

✍ Scribed by P. Lampertico

Book ID: 118648873
Publisher: Elsevier
Year: 2008
Tongue: English
Weight: 94 KB
Volume: 2
Category: Article
ISSN: 1594-5804
DOI: 10.1016/s1594-5804(09)60004-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of entecavir compare

Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China

✍ Guangbi Yao; Chengwei Chen; Weilun Lu; Hong Ren; Deming Tan; Yuming Wang; Daozhe 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 223 KB

Efficacy and safety of entecavir compare

Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China

✍ Guangbi Yao; Chengwei Chen; Weilun Lu; Hong Ren; Deming Tan; Yuming Wang; Daozhe 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 89 KB

Comparison between clevudine and entecav

Comparison between clevudine and entecavir treatment for antiviral-naïve patients with chronic hepatitis B

✍ Hong Joo Kim; Dong Il Park; Jung Ho Park; Yong Kyun Cho; Chong Il Sohn; Woo Kyu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

Loss of HBsAg antigen during treatment w

Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B

✍ R. G. Gish; T.-T. Chang; C.-L. Lai; R. De Man; A. Gadano; F. Poordad; J. Yang; H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

Entecavir resistance is rare in nucleosi

Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

✍ Richard J. Colonno; Ronald Rose; Carl J. Baldick; Steven Levine; Kevin Pokornows 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

a HBV DNA Ͻ7 ϫ 10 5 copies/mL by bDNA assay ϩ loss of HBeAg (Study AI463022) or normalization of ALT (Study AI463027). b HBV DNA Ͻ7 ϫ 10 5 copies/mL by bDNA assay. c HBV DNA Ն7 ϫ 10 5 copies/mL by bDNA assay.

Long-term use of entecavir in nucleoside

Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection

✍ Osamu Yokosuka; Koichi Takaguchi; Shinichi Fujioka; Michiko Shindo; Kazuaki Chay 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 950 KB